Economic Impact of Treating Inhibitor Patients

Publisher： Karger

E-ISSN： 1424-8840|32|1|29-32

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.1, 2002-05, pp. : 29-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials

By Caro J. Jaime   Huybrechts Krista F.   Xenakis James G.   O'Brien Judith A.   Rajagopalan Krithika   Lee Karen  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2233-2242

Informa Healthcare

Access to resources Recommend Favorite

The Economic Impact of Treating Deep Vein Thrombosis with Low-Molecular-Weight Heparin: Outcome of Therapy and Health Economy Aspects

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 8-16

Karger

Access to resources Recommend Favorite

Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US

By Cantor Louis B.   Katz L. Jay   Cheng J. Wang   Chen Er   Tong Kuo B.   Peabody John W.  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2905-2918

Informa Healthcare

Access to resources Recommend Favorite

MTP inhibitor for treating severe LDL cholesterolemia

By Mabuchi Hiroshi   Nohara Atsushi  

Clinical Lipidology, Vol. 8, Iss. 4, 2013-08 ,pp. : 387-389

Future Medicine

Access to resources Recommend Favorite

Impact of Plasma Tissue Inhibitor of Matrix Metalloproteinase-1 on Long-Term Survival in Patients with Colorectal Cancer

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 205-208

Karger

Access to resources Recommend Favorite